We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Home Diagnostics Merges with Nipro Diabetes Systems

By LabMedica International staff writers
Posted on 16 Jun 2010
Home Diagnostics, Inc. More...
(Fort Lauderdale, FL, USA) and Nipro Diabetes Systems, Inc. (Miramar, Florida, USA) announced that the two companies are merging to become Nipro Diagnostics, Inc.

Both companies are wholly owned by Nipro Corporation (Osaka, Japan), a multibillion-dollar company, and a world leader in providing medical products to the healthcare community.

Home Diagnostics manufactures and markets the TRUE brand of quality, high-performance blood glucose monitoring systems. These products are affordable, accurate, and reliable. The company supplies blood glucose monitoring systems for medical products distributors, national retail pharmacies, pharmacy wholesalers, and mail-order suppliers.

Nipro Diabetes Systems manufactures and markets the Amigo insulin pump that helps keep blood glucose in control for children and adults with types 1 and 2 diabetes. Built for safety, reliability, accuracy and durability, the insulin pump features computer like help screens for easy programming.

The merger of the two companies results in a comprehensive diabetes monitoring and insulin-management product portfolio, which few companies offer. This portfolio will help to ensure that patients and healthcare professionals have easy access to high-quality diabetes monitoring and management tools.

The name change to Nipro Diagnostics, Inc. is effective immediately for Home Diagnostics. The merger of the two companies is expected to be completed by the end of the year 2010.

Related Links:

Home Diagnostics, Inc.
Nipro Diabetes Systems, Inc.
Nipro Corporation




Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
ESR Analyzer
TEST1 2.0
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.